This is not the latest version of this item. The latest version can be found here.
Rate of brain aging and APOE ε4 are synergistic risk factors for Alzheimer’s disease
Name
e201900303.full.pdf
Description
Published version
Size
1.85 MB
Format
Adobe PDF
Checksum (MD5)
b6d5d3788e5fb7cee7aeddc6f5a4745a
Author(s)
Glorioso, Christin A
Pfenning, Andreas R
Lee, Sam S
Bennett, David A
Sibille, Etienne L
Kellis, Manolis
Guarente, Leonard P
Date Issued
2019
Journal
Life Science Alliance
Publisher
Life Science Alliance, LLC
Version
Final published version
Abstract
Advanced age and the APOE ϵ4 allele are the two biggest risk factors for Alzheimer's disease (AD) and declining cognitive function. Wedescribe a universal gauge to measuremolecular brain age using transcriptome analysis of four human postmortem cohorts (n = 673, ages 25-97) free of neurological disease. In a fifth cohort of older subjects with or without neurological disease (n = 438, ages 67-108), we show that subjects with brains deviating in the older direction fromwhat would be expected based on chronological age show an increase in AD, Parkinson's disease, and cognitive decline. Strikingly, a younger molecular age (25 yr than chronological age) protects against AD even in the presence of APOE ϵ4. An established DNA methylation gauge for age correlates well with the transcriptome gauge for determination of molecular age and assigning deviations from the expected. Our results suggest that rapid brain aging and APOE ϵ4 are synergistic risk factors, and interventions that slow aging may substantially reduce risk of neurological disease and decline even in the presence of APOE ϵ4.
Terms of Use
Creative Commons Attribution 4.0 International license
Persistent DSpace Link
DOI of Published Version
10.26508/lsa.201900303
